Health Is Cure · 11:00 29 Dec 2023
Earlier this year we reported on FDA’s approval of valoctocogene roxaparvovec (Roctavian) for adults with severe hemophilia A. In this story, we provide an update on what has happene… Read More
Roctavian Blog Posts
Personalized Content… · 15:23 02 Aug 2023
In a world where health is paramount, the pharmaceutical industry stands as a formidable pillar, relentlessly pursuing scientific breakthroughs and life-saving innovations. With each passing… Read More
Congenital Hearing L… · 02:50 24 Jul 2023
causes haemophilia :: Article CreatorWoman Told She Won't Live Past 35 As She Lives With Six Medical Conditions Hanna Hamm is a ticking medical time bomb — th… Read More
Congenital Hearing L… · 02:49 22 Jul 2023
hemophilia factor deficiency :: Article CreatorAbnormal Uterine Bleeding May Be Caused By Clotting Factor DeficienciesA new review article illuminates why physicians… Read More
Congenital Hearing L… · 02:49 05 Jul 2023
hemophilia genetic disorder :: Article CreatorBioMarin's Next Roctavian Challenge Is How To Successfully Commercialize Its Gene Therapy: Warranties May Be An Option… Read More
Health Is Cure · 17:32 29 Jun 2023
The FDA approved valoctocogene roxaparvovec (Roctavian) as the first gene therapy for the treatment of adults with severe hemophilia A, drug developer Biomarin announced on Thursday.
Patie… Read More
4 Finance News · 06:13 07 Mar 2023
BioMarin's Roctavian will get FDA motion date prolonged to finish of June
origin hyperlink Read More
Congenital Hearing L… · 02:49 01 Apr 2023
royal bleeding disease :: Article CreatorHemophilia: Breakthrough Therapies Aim To 'dethrone' The Disease Of Kings © ÓSCAR CORRAL (EL PAÍS) Hemoph… Read More
Best Hotel In Udaip… · 19:04 06 Feb 2023
PEPTIDKUNDE – GHRP 6
Außerdem sind Bluttests empfindlicher, d. Für die Einhaltung der in Ihrem Land geltenden Gesetze und sonstigenRechtsvorschriften sind Sie als Nutzer sel… Read More
Bluzz · 08:28 10 Jan 2023
Report highlights personalized medicines ensuring greater efficacy for rare diseases and previously untreatable conditions
Promising therapeutic developments for HIV, Parkinson's disease… Read More
Cnn Wolrd Today · 16:00 08 Jan 2023
– Mean Annualized Bleed Rate Reduced by 80% from Baseline and Factor VIII Usage Reduced by 94% in Year 3 Compared to Baseline
– 92% of Patients off Prophylaxis at the En… Read More
Personalized Content… · 17:58 24 Nov 2022
In a pivotal approval, the US Food and Drug Administration (FDA) has given the nod to a new gene therapy called Hemgenix (etranacogene dezaparvovecfor) for the treatment of adults with the g… Read More
Clinical Trials News · 11:38 04 Nov 2022
ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter Weekly View November 4, 2022 From the desk of Priya Ranad… Read More
Clinical Trials News · 11:45 16 Sep 2022
ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter Weekly View September 16, 2022 From the desk of Priya Ran… Read More
Clinical Trials News · 11:29 02 Sep 2022
ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter Weekly View September 2, 2022 From the desk of Priya Rana… Read More
Clinical Trials News · 11:43 01 Jul 2022
ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter… Read More
Clinical Trials News · 11:49 06 May 2022
ICER Weekly View View as Webpage Sign up for ICER's Weekly View Newsletter… Read More
Newsfile Corp News R… · 20:15 30 Sep 2020
San Francisco, California--(Newsfile Corp. - September 30, 2020) - Hagens Berman urges BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) investors to contact the firm now. A securities frau… Read More
Buddymantra.in · 19:20 14 Jun 2020
Chewy CEO Sumit Singh (C) rings the opening bell to start the day’s buying and selling for the Chewy Inc. IPO at the New York Inventory Exchange (NYSE), June 14, 2019.Andrew Kelly | Re… Read More